PDCD1 and breast cancer: To elucidate the molecular mechanisms underlying the enhancement of anti-PD-1 treatment efficacy by P.distasonis, we performed RNA sequencing of tumor tissue collected from Pa + mAb group(n=2) and BC + mAb group(n=2).